InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that ...

The US is a country that built its riches with the hard work of its immigrant workers. America’s heavy-handed policies risk ...